Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001209191-22-060691

Chief Financial Officer bought 5,568 shares at an average $1.80 ($10,002)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Amello Jason Chief Financial Officer 2022-12-08 Purchase +3,100 $1.69 $5,239 3,100 D
Amello Jason Chief Financial Officer 2022-12-09 Purchase +2,468 $1.93 $4,763 5,568 D
Open-market purchases · 5,568 sh · avg $1.80 · $10,002
Loading xslF345X03/doc4.xml…